An effective PQS requires an effective system for detection of quality problems, investigation and correction of their cause, and change control. The Efficient CAPA system in line with ICH Q10 will allow the manufacturer to resolve repeat issues and promote continuous improvement. Integration of CAPA and Change Management within ICH Q10 and ICH Q12 will allow maintaining quality of the product throughout its lifecycle.
CAPA and Change Management under ICH Q10 and Q12
Change Management and CAPA are integral parts of ICH Q10, while ICH Q12 helps in managing changes after approval. Changes to processes, machinery, procedures, or controls can be identified using the results of CAPA. Then Change Management will help in evaluating, approving, implementing, and monitoring those changes.
Designing an Effective CAPA System
The process of CAPA is expected to determine the root cause of the issue and not just the solution. Root cause determination techniques that include fishbone analysis and five whys are useful in achieving this objective.
Key practices include:
- Problem definition & scope of investigation
- Root cause identification based on evidence
- Corrective/preventive action assignment
- Completion dates that are realistic
- Effectiveness checks through documentation
These practices support Prevent CAPA recurrence best practices by confirming that actions have addressed the actual cause.
Risk-Based Change Management
The pharmaceutical quality system that uses change management should evaluate each proposed change based on its impact on product quality, process performance, regulatory commitments, and patient safety. The evaluation process will determine how to test, approve, document and monitor the changes.
There should be a link between CAPA and change control under ICH Q12 in terms of risk assessment and lifecycle knowledge. This will enable manufacturers to deal with post-approval changes appropriately.
Integrating CAPA with Continuous Improvement
The outcome of the CAPA needs to influence change management, knowledge management, and process performance monitoring. The following documentation should be used in a good lifecycle controlled change management PQS to ensure that the change was justified, risk assessment was done, and outcomes were expected.
Metrics and Inspection Readiness
Key performance indicators include CAPA repeat, late action items, closing duration, ineffectiveness checks, and deviations caused by changes. Periodic trend reviews and managerial intervention will be able to spot deficiencies and boost inspection preparedness.
Conclusion
A system of CAPA and change management provides for problem avoidance, change control, and quality improvement. The use of risk-based decision-making, proper investigations, proper metrics, and management involvement can help create an inspection-ready PQS.
Frequently Asked Questions
- How do CAPA and change management systems work together under ICH Q10 and ICH Q12?
Quality and Improvements come under CAPA, whereas change management is all about managing changes by risk based lifecycle management.
- What are the best practices for preventing CAPA recurrence in a pharmaceutical quality system?
Root cause analysis, corrective actions, schedules, and effectiveness testing should be undertaken and documented.
- How should a risk-based change management process be designed to support lifecycle control under ICH Q12?
It must evaluate quality and regulatory impacts, specify control measures and keep track of modifications during the life cycle of the product.
- What metrics should companies track to measure the effectiveness of their CAPA system?
The metrics which should be monitored include CAPA repeat, CAPA closure date, CAPA overdue, and effectiveness verification.
- What are the most common weaknesses in CAPA and change management systems that regulators identify during inspections?
This can be ascribed to weaknesses in the RCA process, measurement, CAPA, documentation, and change impact assessment.
